Home » Pfizer Japan Unveils Positive Top-Line Phase III Results for Lyrica in Fibromyalgia
Pfizer Japan Unveils Positive Top-Line Phase III Results for Lyrica in Fibromyalgia
Pharmaceutical giant Pfizer’s Japan unit announced positive top-line results for Lyrica in a Phase III study of patients with fibromyalgia in Japan. The company said that further analyses will be conducted on these initial results.
RTT News
RTT News
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May